Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

European Virus Archive GLOBAL

Descripción del proyecto

Un archivo mundial de virus

El proyecto financiado con fondos europeos EVA-GLOBAL reúne a cuarenta y tres laboratorios asociados con organizaciones no gubernamentales principales como la Organización Mundial de la Salud (OMS) y la Organización Mundial de Sanidad Animal (OIE). La red de EVA-GLOBAL se ha reforzado mediante doce entidades asociadas y cinco redes internacionales asociadas. Esta comunidad internacional avanzada y singular (con doce miembros de la Unión Europea y diecisiete de fuera de la Unión) se propone llegar a ser la red con mayor capacidad de respuesta para mejorar el control de brotes de virus de nueva aparición y resurgentes a escala mundial. El anterior proyecto EVAg, ya ha logrado ejercer un papel fundamental en el control de brotes importantes de virus como el síndrome respiratorio de Oriente Próximo (SROM), el chicungunya, la fiebre de Zika, la enfermedad del Ébola, el dengue o la COVID-19, mediante el suministro de reactivos únicos para la detección de virus en pacientes infectados. A través de nuevos institutos que se incorporarán al consorcio, EVA-G se convertirá en la mayor colección de virus de humanos, animales y plantas.

Objetivo

EVA-GLOBAL gathers 38 academic institutions at the forefront of human, animal and plant research in Virology, associated with key Non-Governmental Organisations including the World Health Organisation, OIE, FAO and related international organizations such as the CGIAR. This new project is built on the strong foundations constituted two previous EVA (2009-2014), FP7 and EVAg (2014-2019), H2020 projects. It includes high calibre institutes with the appropriate expertise to collect, characterise, standardise, authenticate and distribute human, animal and plant viruses. EVA-GLOBAL is conceived to be an open access entity aiming at developing synergies and complementary capabilities in such a way to offer an improved access to the researchers. A single-entry point, the web-based catalogue, gives a facilitate access to the end-user, to the collections including viruses, derived materials and engineered cells. This project will integrate 13 facilities dedicated to the high-risk pathogens manipulations (BSL4), which constitutes the largest BSL4 network worldwide. EVA-GLOBAL will also link up with other network-based virus associated programmes that exist globally. This unique advanced community aims at becoming the most responsive network to improve the control of emerging or re-emerging virus outbreaks at the global level. During the past EVAg project, this infrastructure has already been able to play a key role for the control of emerging virus diseases by the supply of unique reagents for the detection of viruses under the WHO umbrella. Through this new ambitious four-year project and the new institutes joining the consortium, EVA-GLOBAL will become the largest virtual virus collection for human, animal and plant viruses will move beyond the current state-of-the-art to provide an increasingly valuable resource and service to the scientific community, including government health departments, higher education institutes, industry and to the general public as well.

Convocatoria de propuestas

H2020-INFRAIA-2018-2020

Consulte otros proyectos de esta convocatoria

Convocatoria de subcontratación

H2020-INFRAIA-2019-1

Régimen de financiación

RIA - Research and Innovation action

Coordinador

UNIVERSITE D'AIX MARSEILLE
Aportación neta de la UEn
€ 3 360 727,26
Dirección
BOULEVARD CHARLES LIVON 58 LE PHARO
13284 Marseille
Francia

Ver en el mapa

Región
Provence-Alpes-Côte d’Azur Provence-Alpes-Côte d’Azur Bouches-du-Rhône
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
€ 3 710 727,26

Participantes (36)